Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Shailina Keshwani"'
Autor:
Steven M. Smith, Almut G. Winterstein, Matthew J. Gurka, Marta G. Walsh, Shailina Keshwani, Anne M. Libby, William R. Hogan, Carl J. Pepine, Rhonda M. Cooper‐DeHoff
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 1 (2023)
Background Knowledge of real‐world antihypertensive use is limited to prevalent hypertension, limiting our understanding of how treatment evolves and its contribution to persistently poor blood pressure control. We sought to characterize antihypert
Externí odkaz:
https://doaj.org/article/66694bb1ce214b13bdf9b1ba8386bdbc
Autor:
Sebastian Jugl, Aimalohi Okpeku, Brianna Costales, Earl J. Morris, Golnoosh Alipour-Haris, Juan M. Hincapie-Castillo, Nichole E. Stetten, Ruba Sajdeya, Shailina Keshwani, Verlin Joseph, Yahan Zhang, Yun Shen, Lauren Adkins, Almut G. Winterstein, Amie Goodin
Publikováno v:
Medical Cannabis and Cannabinoids, Pp 1-22 (2021)
In 2017, a National Academies of Sciences, Engineering, and Medicine (NASEM) report comprehensively evaluated the body of evidence regarding cannabis health effects through the year 2016. The objectives of this study are to identify and map the most
Externí odkaz:
https://doaj.org/article/eeee2674e8494a189a09eff8a1aae286
Autor:
Kayla M Smith, Almut G Winterstein, Matthew J Gurka, Marta Walsh, Shailina Keshwani, Anne Libby, William Hogan, Carl J Pepine, Rhonda M Cooper-Dehoff, Steven M Smith
Publikováno v:
Circulation. 147
Introduction: Early treatment for hypertension (HTN) portends better outcomes. However, few real-world studies have assessed initial antiHTN regimens and how they differ by baseline blood pressure (BP). We sought to compare initial treatment patterns
Autor:
Steven M. Smith, Almut G. Winterstein, Matthew J. Gurka, Marta G. Walsh, Shailina Keshwani, Anne M. Libby, William R. Hogan, Carl J. Pepine, Rhonda M. Cooper‐DeHoff
Publikováno v:
Journal of the American Heart Association.
Background Knowledge of real‐world antihypertensive use is limited to prevalent hypertension, limiting our understanding of how treatment evolves and its contribution to persistently poor blood pressure control. We sought to characterize antihypert
Autor:
Shailina Keshwani, Golnoosh Alipour-Haris, Ruba Sajdeya, Yahan Zhang, Verlin Joseph, Almut G. Winterstein, Brianna Costales, Lauren E. Adkins, Earl J. Morris, Sebastian Jugl, Juan M Hincapie-Castillo, Nichole E. Stetten, Aimalohi Okpeku, Amie Goodin, Yun Shen
Publikováno v:
Medical Cannabis and Cannabinoids, Pp 1-22 (2021)
Med Cannabis Cannabinoids
Med Cannabis Cannabinoids
In 2017, a National Academies of Sciences, Engineering, and Medicine (NASEM) report comprehensively evaluated the body of evidence regarding cannabis health effects through the year 2016. The objectives of this study are to identify and map the most
Autor:
Juan M Hincapie-Castillo, Scott Martin Vouri, Shailina Keshwani, Ivanna Grande, Michael Maguire, Amie Goodin
Publikováno v:
JAMA Network Open
This quality improvement study examines changes in the prescribing and use of prescription nonsteroidal anti-inflammatory drugs (NSAIDs) after implementation of a law restricting the prescription of opioids in Florida.
Key Points Question Was im
Key Points Question Was im
Autor:
Shailina Keshwani, Michael Maguire, Amie Goodin, Wei-Hsuan Lo-Ciganic, Debbie L. Wilson, Juan M. Hincapie-Castillo
Publikováno v:
JAMA Health Forum. 3:e221757
State Medicaid programs have implemented initiatives to expand treatment coverage for opioid use disorder (OUD); however, some Medicaid programs still require prior authorizations (PAs) for filling buprenorphine prescriptions.To evaluate the changes
Autor:
Sebastian Jugl, Aimalohi Okpeku, Brianna Costales, Earl Morris, Golnoosh Alipour-Harris, Juan Hincapie-Castillo, Nichole Stetten, Ruba Sajdeya, Shailina Keshwani, Verlin Joseph, Yahan Zhang, Yun Shen, Lauren Adkins, Amie Goodin
Publikováno v:
Abstracts from the 2020 Virtual Scientific Meeting of the Research Society on Marijuana July 24th, 2020.
Background: Medical cannabis is available to patients by physician order in two-thirds of the United States (U.S.) as of 2020, but remains classified as an illicit substance by federal law. States that permit medical cannabis ordered by a physician t
Autor:
Coy D. Heldermon, Sebastian Jugl, Almut G. Winterstein, Shailina Keshwani, Lauren E. Adkins, Amie Goodin
Publikováno v:
Journal of Clinical Oncology. 38:12091-12091
12091 Background: Medical cannabis use is increasing significantly in the United States as states reduce restrictions. However, ambiguity concerning the evidence for medical cannabis efficacy and safety, especially in the field of oncology, is persis